Skip to main content

Pitt to Use WaferGen SmartChip in NIH-Supported Studies

NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that the University of Pittsburgh will use its SmartChip Real-Time PCR System in genomics, gene expression, and disease studies that are funded by the National Institutes of Health.

The Pittsburgh researchers are using $350,000 of a $3.5 million American Recovery and Reinvestment Act grant to support their efforts. The award is partially funding two research programs conducted under a collaboration with Pittsburgh, Harvard University, Boston University, National Jewish Hospital, and Wake Forest University.

One program aims to create a genetic, molecular, and quantitative clinical phenotyping data warehouse that will be used in studies of disease pathogenesis and help refine diagnostic criteria for use in addressing chronic lung disease. Another genomics project will focus on understanding why some individuals with asthma are more difficult to treat than others.

Both of these projects will use the SmartChip technology for high-throughput PCR validation, the company said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.